2020-000696-20
This study will evaluate the effectiveness of a single dose of Baloxavir Marboxil to prevent the spread of influenza virus infection
Shionogi & Co., Ltd.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Influenza
Sponsor & location
- Primary sponsor
- Shionogi & Co., Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Proportion of subjects who are infected with influenza virus (RT-PCR positive), and present with fever and at least one respiratory symptom
ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2020-000696-20
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2020-000696-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Shionogi & Co., Ltd. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.